Mesothelioma Treatment Analyzed as a Second-Line Approach

Retreatment with cisplatin plus pemetrexed was generally well tolerated. Retreatment with cisplatin and pemetrexed is a potential therapeutic option for certain patients with recurrent epithelioid malignant pleural mesothelioma, possibly including those who show tumor regression with a time to progression of six months or more after the initial chemotherapy.